ReGen Factor offers hair restoration and anti-aging skin treatment solutions to med-spa owners, medical practitioners, DOs, RNs, and aesthetic professionals globally. ReGen Factor operates in the multi-billion global anti-aging and hair restoration markets. ReGen Factor’s offerings deliver “never seen before” results for anti-aging face and skin treatments in addition to unparalleled solutions for hair restoration with safe, fast, and effective treatments. ReGen Factor is the owner of PepFactor Skin and PepFactor Scalp cosmetic treatments globally and are headquartered in Sydney, Australia.
“This is an important milestone for ReGen Factor,” said Stephen Blignaut, CEO of ReGen Factor. “We thoughtfully curated this board to include hair transplant, general medicine, med-spa and marketing industry experts whose collective experience ensures ReGen Factor has the guidance it needs to navigate its way in the dynamic anti-aging and hair restoration markets.
ReGen Factor is a company delivering disruptive solutions in the anti-aging skin and hair restoration markets offering new age products; PepFactor Scalp and PepFactor skin treatments for fast and never seen before results.
The Powerful Healing Capabilities of Bioidentical FGFs and Their Potential to Increase Lifespan: A Comprehensive Overview Bioidentical Fibroblast Growth Factors (FGFs) represent a groundbreaking advancement
5 September 2024 Regen Factor: A Revolutionary Opportunity in Regenerative Medicine Introduction Dear Prospective Investor/Investor, Imagine a world where healing from a debilitating injury is
The most impactful and potentially popular bioidentical FGF’s Here’s a focused selection of the most impactful and potentially popular bioidentical FGFs, highlighting their powerful healing
White Paper Outline: The Distinction Between Non-Bioidentical and Bioidentical rh bFGF and the Pioneering Role of Regen Factor Introduction Overview of Fibroblast Growth Factors (FGFs)
Send Us A Message
Get In Touch!
Fill out the form below, and we will be in touch shortly.